title: Next-generation NovaSure device for endometrial ablation: assessing ease-of-use among physicians.
abstract: OBJECTIVE
  To compare physician assessment of the next-generation NovaSure(®) device to the original NovaSure device.
  
  
  METHODS
  Prospective open-label, unblinded survey utilizing Likert scales.
  
  
  METHODS
  Community-based obstetrician and gynecology practices.
  
  
  METHODS
  There were 270 evaluations completed by 168 physicians for women undergoing endometrial ablation with the next-generation NovaSure device compared to the previous model.
  
  
  METHODS
  Physician survey across multiple community-based obstetrician and gynecology practices.
  
  
  RESULTS
  In general, 53.7% of women had a normal uterus, with an average cavity length of 5.3 cm ± 0.9 cm, and 44.7% of women had a normal cervix. Overall, 98.7% of physicians agreed or strongly agreed that they were satisfied with the performance of the next-generation NovaSure device compared with the previous device. Additionally, 89% of physicians rated the next-generation NovaSure device as superior to the previous device. The best rated features were the SureFit™ Cervical Seal, Smooth Access™ Tips, and the thumb-pusher. No adverse events were reported in this study.
  
  
  CONCLUSIONS
  Community-based physicians rated the next-generation NovaSure device as superior to the previous model in a general population of women.
authors.affiliation: The Gynecology Center, Pottsville, PA, USA.
authors.forename: Whitney
authors.initials: W
authors.lastname: Pollock
authors.forename: William
authors.initials: W
authors.lastname: Jamieson